Abstract
To test the hypothesis that prostaglandins are cytoprotective in the human large intestine, we investigated the effect of withdrawal of treatment with indomethacin suppositories on bowel habit and on rectal mucosal electrolyte transport and prostaglandin production in 8 patients taking such treatment for rheumatological disorders. Discontinuation of indomethacin doubled rectal mucosal prostaglandin E2 release (p<0.05) measured byin vivo rectal dialysis. Although there was no significant overall change in stool frequency, stool consistency, rectal bleeding or sodium absorption (also assessed by rectal dialysis), sigmoidoscopic appearance (p=0.05), rectal mucosal potential difference (p<0.05) and potassium transport (p=0.01) each reverted towards normal on indomethacin withdrawal. These results accord with the theory that, as in the upper gastrointestinal tract, prostaglandins may play a role in the maintenance of rectal mucosal structure and function.
Similar content being viewed by others
References
A. Roberts,Cytoprotection by prostaglandins, Gastroenterology77, 761–767 (1979).
S. Coutrot, D. Roland, J. Barbier, P. van der Marq, M. Alcalay andC. Matuchansky,Acute perforation of colonic diverticula associated with shortterm indomethacin, Lancet2, 1055–1056 (1978).
D.S. Rampton, N.I. McNeil andM. Sarner,Analgesic ingestion and other factors preceding relapse in ulcerative colitis, Gut24, 187–189 (1983).
D.S. Rampton andG.E. Sladen,Relapse of ulcerative proctocolitis during treatment with non-steroidal antiinflammatory drugs, Postgrad. med. J.57, 297–299 (1981).
D.S. Rampton andG.E. Sladen,Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment, Prostaglandins21, 417–425 (1981).
N. Levy andE. Gaspar,Rectal bleeding and indomethacin suppositories, Lancet,1, 577 (1975).
H. Berry, D. Swinson, H. Jones andE.B.D. Hamilton,Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis, Ann. rheum. Dis.37, 370–372 (1978).
V. Wright andR. Hopkins,A note on indomethacin suppositories in rheumatic conditions, Rheumatol. Rehab.18, 186–187 (1979).
J.H. Baron, A.M. Connell andJ.E. Lennard-Jones,Variation between observers in describing mucosal appearances in proctocolitis, Br. med. J.1, 89–93 (1964).
C.J. Edmonds andD. Pilcher,Electrical potential difference and sodium potassium fluxes across the rectal mucosa in ulcerative colitis, Gut14, 784–789 (1973).
D.S. Rampton, G.E. Sladen andL.J.F. Youlten,Rectal mucosal prostaglandin E 2 release and its relation to disease activity, electrical potential difference and treatment in ulcerative colitis, Gut21, 591–596 (1980).
J. Rask-Madsen andP. Brix-Jensen,Electrolyte transport capacity and electrical potentials of the normal and inflamed human rectum in vivo, Scand. J. Gastroent.8, 169–175 (1973).
D.S. Rampton, G.E. Sladen, K.K. Bhakoo, D.I. Heinzelmann andL.J.F. Youlten,Rectal mucosal prostaglandin E release and electrolyte transport in ulcerative colitis, Adv. Prostaglandin & Thromboxane Res.8, 1621–1625 (1980).
A. Robert, J.E. Nezamis, C. Lancaster andA.J. Hanchar,Prevention, through cytoprotection, of clindamycin-induced colitis in hamsters with 16,16-dimethyl PGE 2, Gastroenterology78, 1245 (1980).
I.R.G. Jones andJ.V. Psaila,Cytoprotection by PGE 2 in the rat colon, Scand. J. Gastroent.17, Suppl. 78, 416 (1982).
J.R.S. Hoult andP.K. Moore,Sulphasalazine is a potent inhibitor of PG 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis, Br. J. Pharmac.64, 6–8 (1978).
R.J. Flower,Drugs which inhibit prostaglandin biosynthesis, Pharmac. Rev.23, 33–66 (1974).
C. Matuchansky andS. Coutrot,The role of prostaglandins in the study of intestinal water and electrolyte transport in man, Biomedicine28, 143–148 (1978).
K. Bukhave andJ. Rask-Madsen,Saturation kinetics applied to in vitro effects of low prostaglandin E 2 and F2α concentrations on ion transport across human jejunal mucosa, Gastroenterology78, 32–42 (1980).
E. Beubler andH. Juan,Is the effect of diphenolic laxatives mediated via release of prostaglandin E?, Experientia34, 386–387 (1978).
J. Hardcastle, P.T. Hardcastle andJ.S. Redfern,The effect of prostacyclin on intestinal ion transport in the rat, Life Sci.26, 123–131 (1980).
L.C. Racusen andH.J. Binder,Effect of prostaglandin on ion transport across isolated colonic mucosa, Dig. Dis. Sci.25, 900–904 (1980).
D.S. Rampton, N.F. Breuer, S.G. Vaja, G.E. Sladen andR.H. Dowling,Role of prostaglandins in bile salt-induced changes in rat colonic structure and function, Clin. Sci.61, 641–648 (1981).
M. Taub, M.J. Coyne, G.G. Bonorris, A. Chung, B. Coyne andL.J. Schoenfield,Inhibition by propranolol of bile acid and PGE 1-stimulated cAMP and intestinal secretion, Am. J. Gastroent.70, 129–135 (1978).
G.J. Milton-Thompson, J.H. Cummings, A. Newman, J.A. Billings andJ.J. Misiewicz,Colonic and small intestinal response to intravenous prostaglandin F 2α and E2 in man, Gut16, 42–46 (1975).
D.M. Engineer, U. Neiderhauser andP.J. Piper,Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substances of anaphylaxis and histamine, Br. J. Pharmac.62, 61–66 (1978).
M. Musch, R.J. Miller, M. Field andM. Siegel,Stimulation of colonic secretion by lipoxygenase metabolites of arachidonic acid, Science, N.Y.217, 1255–1256 (1982).
R. Marcolongo, P.F. Bayeli andM. Montagnani,Gastrointestinal involvement in rheumatoid arthritis: a biopsy study, J. Rheumatol.6, 163–173 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rampton, D.S., Barton, T.P. Are prostaglandins cytoprotective in the human large intestine?—the effect of indomethacin on rectal mucosal function and prostaglandin E2 releasein vivo . Agents and Actions 14, 715–718 (1984). https://doi.org/10.1007/BF01978913
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01978913